$3.6 Billion Microfluidics Market, 2022

Dublin, June 21, 2018 (GLOBE NEWSWIRE) -- The "Microfluidics Market - By Material (Ceramics, Polymers), By Components (Microfluidic Chips, Pumps, Needles), By Application (In-Vitro Diagnostics, Pharmaceutical Research, Drug Delivery) - World Forecasts to 2022" report has been added to ResearchAndMarkets.com's offering.

The market for microfluidic devices all over the world was worth US$ 3.6 Billion in 2017, and is poised for a double digit growth during the forecasted period (2017-2022).

This growth is likely to be driven by the rising demand for point-of-care devices, quick return on investments provided by microfluidics devices resulting in cost reductions, and miniaturization of microfluidic chips.

On the contrary, manufacturing difficulties and high capital investment for lab-on-chip devices are two of the major challenges faced by this sector. Other major factors such as tough incorporation of emerging microfluidic technologies into existing workflows, and complex and time consuming regulatory standards are hampering the growth of microfluidics market.

According to analysis, The new report also focuses on microfluidics market by material, such as ceramics, polymers, glass, and silicon; by components, such as microfluidic chips, pumps, and needles; by application, and territory. The In-Vitro diagnostics segment commands the largest share of the global microfluidics applications market. The large share of this segment is attributed to the increasing adoption of microfluidics for Point-of-Care & Clinical and Veterinary diagnostics application by major diagnostic companies, such as Roche, Becton Dickinson and Company, Abbott, and Cepheid amongst others. Similarly, in microfluidics by components segment, microfluidic chips accounted for the largest share. This large share is attributed to increasing usage of these chips in IVD application.

Based on material, in 2017, ceramics contributed the major share in microfluidics market. This high share is attributed to high chemical resistivity, versatility, and strength offered by ceramics in manufacturing of microfluidics devices.

Asia Pacific is poised to witness a lucrative growth in the coming years. This is attributed to the increasing mergers and acquisitions, and technological advancements in emerging countries. However, North America accounted for the largest share in 2017. The increasing adoption of microfluidics technology and the incessant launches of new products in the North American region are driving the market growth.

In addition, this study also covers latest trends and developments capturing the market since last few years. The report also includes the regulatory scenario in various countries across the globe.

The key vendors dominating the market space are Fluidigm Corp., Roche, Agilent Technologies Inc., Illumina, Inc., Shimadzu, Abbott, etc. Finally, the report covers strengths and weaknesses, and recent developments on the competitive front. Thus, it provides a comprehensive analysis of the microfluidics technology, which will enable investors and debut makers to design relevant business strategies to target the billion dollar market.

Key Topics Covered:

1. Analyst View

2. Research Methodology

3. Microfluidics - An Introduction

4. Microfluidics Market Overview
4.1 Microfluidics Market
4.2 Healthcare Microfluidics Market

5. Drivers & Challenges
5.1 Drivers
5.1.1 Rising Incidence of Chronic Diseases
5.1.2 Increasing Demand of Point of Care Diagnostics
5.1.3 Rising Application in Life Sciences Research
5.1.4 Benefits of Miniaturization of Chip
5.2 Challenges
5.2.1 Manufacturing Difficulties & High Cost of Lab-on Chips Instruments
5.2.2 Ambiguous Regulatory Framework
5.2.3 Lack of Awareness in Emerging Markets

6. Market Segmentation
6.1 By Material
6.1.1 Ceramics
6.1.2 Polymers
6.1.3 Others
6.2 By Components
6.2.1 Microfluidics Chips Based Microfluidic Devices
6.2.2 Microfluidics Pumps Based Microfluidic Devices
6.2.3 Microfluidics Needles Based Microfluidic Devices
6.2.4 Others
6.3 By Applications
6.3.1 In-Vitro Diagnostics
6.3.2 Pharmaceutical & Life Sciences Research
6.3.3 Drug Delivery
6.3.4 Others
6.4 By Geography
6.4.1 North America
6.4.2 Europe
6.4.3 Asia Pacific
6.4.4 Rest of World

7. Regulatory Scenario
7.1 US
7.2 Europe
7.3 Asia-Pacific
7.3.1 India
7.3.2 China

8. Trends & Developments
8.1 Grants Announced for Microfluidics Research
8.2 Mergers & Acquisitions

9. Competitive Assessment
9.1 Fluidigm Corporation
9.2 F. Hoffmann-La Roche Ltd.
9.3 Bio-Rad Laboratories, Inc.
9.4 Thermo Fisher Scientific, Inc.
9.5 Agilent Technologies, Inc.
9.6 Perkin Elmer, Inc.
9.7 Illumina, Inc.
9.8 Shimadzu Corporation
9.9 Danaher Corporation
9.10 Abbott

For more information about this report visit https://www.researchandmarkets.com/research/xg4m7q/3_6_billion?w=12

                    
                    
                    CONTACT: ResearchAndMarkets.com
                             Laura Wood, Senior Manager
                             press@researchandmarkets.com
                             For E.S.T Office Hours Call 1-917-300-0470
                             For U.S./CAN Toll Free Call 1-800-526-8630
                             For GMT Office Hours Call +353-1-416-8900
                             Related Topics: Drug Delivery, Drug Discovery, In Vitro Diagnostics, Infusions and Injectables , Needles and Syringes